ALERTS & COVID-19 UPDATES Learn more: COVID-19 Resources; COVID-19 Testing; Vaccine Info; Visitor Policy; Support Us

[LCID Study Number: 2015-030CIRB]

NRG-BR002: A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic body Radiotherapy(SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

The main objective of this study is to determine whether removal of metastases (through stereotactic body radiation therapy [SBRT] and/or surgical resection) in oligometastatic breast cancer patients significantly improves overall survival.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-7890